U.S. flag

An official website of the United States government

NM_000520.6(HEXA):c.1264C>G (p.Leu422Val) AND not provided

Germline classification:
Uncertain significance (2 submissions)
Last evaluated:
Oct 12, 2021
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001356326.14

Allele description [Variation Report for NM_000520.6(HEXA):c.1264C>G (p.Leu422Val)]

NM_000520.6(HEXA):c.1264C>G (p.Leu422Val)

Gene:
HEXA:hexosaminidase subunit alpha [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
15q23
Genomic location:
Preferred name:
NM_000520.6(HEXA):c.1264C>G (p.Leu422Val)
HGVS:
  • NC_000015.10:g.72346593G>C
  • NG_009017.2:g.34587C>G
  • NM_000520.6:c.1264C>GMANE SELECT
  • NM_000520.6:c.1264C>G
  • NM_001318825.2:c.1297C>G
  • NP_000511.2:p.Leu422Val
  • NP_001305754.1:p.Leu433Val
  • NC_000015.9:g.72638934G>C
  • NG_009017.1:g.34587C>G
  • NM_000520.4:c.1264C>G
Protein change:
L422V
Links:
dbSNP: rs774562271
NCBI 1000 Genomes Browser:
rs774562271
Molecular consequence:
  • NM_000520.6:c.1264C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001318825.2:c.1297C>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001551461Department of Pathology and Laboratory Medicine, Sinai Health System - The Canadian Open Genetics Repository (COGR)

See additional submitters

no assertion criteria provided
Uncertain significanceunknownclinical testing

SCV002050255ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
criteria provided, single submitter

(ARUP Molecular Germline Variant Investigation Process 2021)
Uncertain significance
(Oct 12, 2021)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedunknownyesnot providednot providednot providednot providednot providedclinical testing
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From Department of Pathology and Laboratory Medicine, Sinai Health System - The Canadian Open Genetics Repository (COGR), SCV001551461.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

The HEXA p.Leu422Val variant was not identified in the literature nor was it identified in ClinVar. The variant was identified in dbSNP (ID: rs774562271) and in control databases in 4 of 251460 chromosomes at a frequency of 0.00001591 (Genome Aggregation Database March 6, 2019, v2.1.1). The variant was observed in the Latino population in 4 of 34592 chromosomes (freq: 0.000116), but was not observed in the African, Ashkenazi Jewish, East Asian, European (Finnish), European (non-Finnish), Other, or South Asian populations. The p.Leu422 residue is conserved in mammals and computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) provide inconsistent predictions regarding the impact to the protein; this information is not very predictive of pathogenicity. The variant occurs outside of the splicing consensus sequence and 4 of 4 in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) predict a greater than 10% difference in splicing. However, this has not been confirmed by RNA analysis and is not predictive enough to assume pathogenicity. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownyesnot providednot providednot providednot providednot providednot providednot provided

From ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories, SCV002050255.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

The HEXA c.1264C>G; p.Leu422Val variant (rs774562271), to our knowledge, is not reported in the medical literature but is reported in ClinVar (Variation ID: 841751). This variant is found in the Latino population with an overall allele frequency of 0.01% (4/34592 alleles) in the Genome Aggregation Database. The leucine at codon 422 is highly conserved, and computational analyses predict that this variant is deleterious (REVEL: 0.845). Additionally, computational analyses of splicing (Alamut v.2.11) predict that this variant may impact splicing by creating a novel cryptic donor splice site, although RNA studies would be required to confirm this. Given the lack of clinical and functional data, the significance of the p.Leu422Val variant is uncertain at this time.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 26, 2024